Selected research
Market Outlook & Growth Opportunities
Global Pathology Imaging Systems Market Outlook and Growth Opportunities 2026
Market perspective
The global Pathology Imaging Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pathology Imaging Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pathology Imaging Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pathology Imaging Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pathology Imaging Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pathology Imaging Systems market include Winning Health Technology Group Co.,Ltd., Beijing Wandong Medical Technology Co.,Ltd., Hangzhou Century Co.,Ltd, Imsight, Micro-tech (nanjing) Co.,ltd., Motic (Xiamen)Electric, Landing Med, Huayin Medical Laboratory and Neusoft Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pathology Imaging Systems market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pathology Imaging Systems and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pathology Imaging Systems revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathology Imaging Systems market.
Pathology Imaging Systems Segment by Company
Winning Health Technology Group Co.,Ltd.
Beijing Wandong Medical Technology Co.,Ltd.
Hangzhou Century Co.,Ltd
Imsight
Micro-tech (nanjing) Co.,ltd.
Motic (Xiamen)Electric
Landing Med
Huayin Medical Laboratory
Neusoft Group
Siemens
Sakura Finetek
Philips Healthcare
Perkin Elmer
Olympus Corporation
Leica Biosystems
Hamamatsu Photonics
GE Healthcare
DigiPath
Carl Zeiss Meditec
3D-Histech
Pathology Imaging Systems Segment by Type
Imaging Systems
Accessories and Software Services
Pathology Imaging Systems Segment by Application
Hospitals
Clinics
Others
Pathology Imaging Systems Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Pathology Imaging Systems status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pathology Imaging Systems key companies, revenue, market share, and recent developments.
3. To split the Pathology Imaging Systems breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pathology Imaging Systems market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pathology Imaging Systems significant trends, drivers, influence factors in global and regions.
6. To analyze Pathology Imaging Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Imaging Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathology Imaging Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Imaging Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathology Imaging Systems industry.
Chapter 3: Detailed analysis of Pathology Imaging Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pathology Imaging Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pathology Imaging Systems in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Imaging Systems
- Accessories and Software Services
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Winning Health Technology Group Co.,Ltd.
- Beijing Wandong Medical Technology Co.,Ltd.
- Hangzhou Century Co.,Ltd
- Imsight
- Micro-tech (nanjing) Co.,ltd.
- Motic (Xiamen)Electric
- Landing Med
- Huayin Medical Laboratory
- Neusoft Group
- Siemens
- Sakura Finetek
- Philips Healthcare
- Perkin Elmer
- Olympus Corporation
- Leica Biosystems
- Hamamatsu Photonics
- GE Healthcare
- DigiPath
- Carl Zeiss Meditec
- 3D-Histech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pathology Imaging Systems Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pathology Imaging Systems Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pathology Imaging Systems Market Dynamics
- 2.1 Pathology Imaging Systems Industry Trends
- 2.2 Pathology Imaging Systems Industry Drivers
- 2.3 Pathology Imaging Systems Industry Opportunities and Challenges
- 2.4 Pathology Imaging Systems Industry Restraints
3 Pathology Imaging Systems Market by Company
- 3.1 Global Pathology Imaging Systems Company Revenue Ranking in 2025
- 3.2 Global Pathology Imaging Systems Revenue by Company (2021-2026)
- 3.3 Global Pathology Imaging Systems Company Ranking (2024-2026)
- 3.4 Global Pathology Imaging Systems Company Manufacturing Base and Headquarters
- 3.5 Global Pathology Imaging Systems Company Product Type and Application
- 3.6 Global Pathology Imaging Systems Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pathology Imaging Systems Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pathology Imaging Systems Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pathology Imaging Systems Market by Type
- 4.1 Pathology Imaging Systems Type Introduction
- 4.1.1 Imaging Systems
- 4.1.2 Accessories and Software Services
- 4.2 Global Pathology Imaging Systems Sales Value by Type
- 4.2.1 Global Pathology Imaging Systems Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pathology Imaging Systems Sales Value by Type (2021-2032)
- 4.2.3 Global Pathology Imaging Systems Sales Value Share by Type (2021-2032)
5 Pathology Imaging Systems Market by Application
- 5.1 Pathology Imaging Systems Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Pathology Imaging Systems Sales Value by Application
- 5.2.1 Global Pathology Imaging Systems Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pathology Imaging Systems Sales Value by Application (2021-2032)
- 5.2.3 Global Pathology Imaging Systems Sales Value Share by Application (2021-2032)
6 Pathology Imaging Systems Regional Value Analysis
- 6.1 Global Pathology Imaging Systems Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pathology Imaging Systems Sales Value by Region (2021-2032)
- 6.2.1 Global Pathology Imaging Systems Sales Value by Region: 2021-2026
- 6.2.2 Global Pathology Imaging Systems Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pathology Imaging Systems Sales Value (2021-2032)
- 6.3.2 North America Pathology Imaging Systems Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pathology Imaging Systems Sales Value (2021-2032)
- 6.4.2 Europe Pathology Imaging Systems Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pathology Imaging Systems Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pathology Imaging Systems Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pathology Imaging Systems Sales Value (2021-2032)
- 6.6.2 South America Pathology Imaging Systems Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pathology Imaging Systems Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pathology Imaging Systems Sales Value Share by Country, 2025 VS 2032
7 Pathology Imaging Systems Country-level Value Analysis
- 7.1 Global Pathology Imaging Systems Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pathology Imaging Systems Sales Value by Country (2021-2032)
- 7.2.1 Global Pathology Imaging Systems Sales Value by Country (2021-2026)
- 7.2.2 Global Pathology Imaging Systems Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pathology Imaging Systems Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pathology Imaging Systems Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pathology Imaging Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Winning Health Technology Group Co.,Ltd.
- 8.1.1 Winning Health Technology Group Co.,Ltd. Company Information
- 8.1.2 Winning Health Technology Group Co.,Ltd. Business Overview
- 8.1.3 Winning Health Technology Group Co.,Ltd. Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.1.4 Winning Health Technology Group Co.,Ltd. Pathology Imaging Systems Product Portfolio
- 8.1.5 Winning Health Technology Group Co.,Ltd. Recent Developments
- 8.2 Beijing Wandong Medical Technology Co.,Ltd.
- 8.2.1 Beijing Wandong Medical Technology Co.,Ltd. Company Information
- 8.2.2 Beijing Wandong Medical Technology Co.,Ltd. Business Overview
- 8.2.3 Beijing Wandong Medical Technology Co.,Ltd. Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.2.4 Beijing Wandong Medical Technology Co.,Ltd. Pathology Imaging Systems Product Portfolio
- 8.2.5 Beijing Wandong Medical Technology Co.,Ltd. Recent Developments
- 8.3 Hangzhou Century Co.,Ltd
- 8.3.1 Hangzhou Century Co.,Ltd Company Information
- 8.3.2 Hangzhou Century Co.,Ltd Business Overview
- 8.3.3 Hangzhou Century Co.,Ltd Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.3.4 Hangzhou Century Co.,Ltd Pathology Imaging Systems Product Portfolio
- 8.3.5 Hangzhou Century Co.,Ltd Recent Developments
- 8.4 Imsight
- 8.4.1 Imsight Company Information
- 8.4.2 Imsight Business Overview
- 8.4.3 Imsight Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.4.4 Imsight Pathology Imaging Systems Product Portfolio
- 8.4.5 Imsight Recent Developments
- 8.5 Micro-tech (nanjing) Co.,ltd.
- 8.5.1 Micro-tech (nanjing) Co.,ltd. Company Information
- 8.5.2 Micro-tech (nanjing) Co.,ltd. Business Overview
- 8.5.3 Micro-tech (nanjing) Co.,ltd. Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.5.4 Micro-tech (nanjing) Co.,ltd. Pathology Imaging Systems Product Portfolio
- 8.5.5 Micro-tech (nanjing) Co.,ltd. Recent Developments
- 8.6 Motic (Xiamen)Electric
- 8.6.1 Motic (Xiamen)Electric Company Information
- 8.6.2 Motic (Xiamen)Electric Business Overview
- 8.6.3 Motic (Xiamen)Electric Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.6.4 Motic (Xiamen)Electric Pathology Imaging Systems Product Portfolio
- 8.6.5 Motic (Xiamen)Electric Recent Developments
- 8.7 Landing Med
- 8.7.1 Landing Med Company Information
- 8.7.2 Landing Med Business Overview
- 8.7.3 Landing Med Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.7.4 Landing Med Pathology Imaging Systems Product Portfolio
- 8.7.5 Landing Med Recent Developments
- 8.8 Huayin Medical Laboratory
- 8.8.1 Huayin Medical Laboratory Company Information
- 8.8.2 Huayin Medical Laboratory Business Overview
- 8.8.3 Huayin Medical Laboratory Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.8.4 Huayin Medical Laboratory Pathology Imaging Systems Product Portfolio
- 8.8.5 Huayin Medical Laboratory Recent Developments
- 8.9 Neusoft Group
- 8.9.1 Neusoft Group Company Information
- 8.9.2 Neusoft Group Business Overview
- 8.9.3 Neusoft Group Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.9.4 Neusoft Group Pathology Imaging Systems Product Portfolio
- 8.9.5 Neusoft Group Recent Developments
- 8.10 Siemens
- 8.10.1 Siemens Company Information
- 8.10.2 Siemens Business Overview
- 8.10.3 Siemens Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.10.4 Siemens Pathology Imaging Systems Product Portfolio
- 8.10.5 Siemens Recent Developments
- 8.11 Sakura Finetek
- 8.11.1 Sakura Finetek Company Information
- 8.11.2 Sakura Finetek Business Overview
- 8.11.3 Sakura Finetek Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.11.4 Sakura Finetek Pathology Imaging Systems Product Portfolio
- 8.11.5 Sakura Finetek Recent Developments
- 8.12 Philips Healthcare
- 8.12.1 Philips Healthcare Company Information
- 8.12.2 Philips Healthcare Business Overview
- 8.12.3 Philips Healthcare Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.12.4 Philips Healthcare Pathology Imaging Systems Product Portfolio
- 8.12.5 Philips Healthcare Recent Developments
- 8.13 Perkin Elmer
- 8.13.1 Perkin Elmer Company Information
- 8.13.2 Perkin Elmer Business Overview
- 8.13.3 Perkin Elmer Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.13.4 Perkin Elmer Pathology Imaging Systems Product Portfolio
- 8.13.5 Perkin Elmer Recent Developments
- 8.14 Olympus Corporation
- 8.14.1 Olympus Corporation Company Information
- 8.14.2 Olympus Corporation Business Overview
- 8.14.3 Olympus Corporation Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.14.4 Olympus Corporation Pathology Imaging Systems Product Portfolio
- 8.14.5 Olympus Corporation Recent Developments
- 8.15 Leica Biosystems
- 8.15.1 Leica Biosystems Company Information
- 8.15.2 Leica Biosystems Business Overview
- 8.15.3 Leica Biosystems Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.15.4 Leica Biosystems Pathology Imaging Systems Product Portfolio
- 8.15.5 Leica Biosystems Recent Developments
- 8.16 Hamamatsu Photonics
- 8.16.1 Hamamatsu Photonics Company Information
- 8.16.2 Hamamatsu Photonics Business Overview
- 8.16.3 Hamamatsu Photonics Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.16.4 Hamamatsu Photonics Pathology Imaging Systems Product Portfolio
- 8.16.5 Hamamatsu Photonics Recent Developments
- 8.17 GE Healthcare
- 8.17.1 GE Healthcare Company Information
- 8.17.2 GE Healthcare Business Overview
- 8.17.3 GE Healthcare Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.17.4 GE Healthcare Pathology Imaging Systems Product Portfolio
- 8.17.5 GE Healthcare Recent Developments
- 8.18 DigiPath
- 8.18.1 DigiPath Company Information
- 8.18.2 DigiPath Business Overview
- 8.18.3 DigiPath Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.18.4 DigiPath Pathology Imaging Systems Product Portfolio
- 8.18.5 DigiPath Recent Developments
- 8.19 Carl Zeiss Meditec
- 8.19.1 Carl Zeiss Meditec Company Information
- 8.19.2 Carl Zeiss Meditec Business Overview
- 8.19.3 Carl Zeiss Meditec Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.19.4 Carl Zeiss Meditec Pathology Imaging Systems Product Portfolio
- 8.19.5 Carl Zeiss Meditec Recent Developments
- 8.20 3D-Histech
- 8.20.1 3D-Histech Company Information
- 8.20.2 3D-Histech Business Overview
- 8.20.3 3D-Histech Pathology Imaging Systems Revenue and Gross Margin (2021-2026)
- 8.20.4 3D-Histech Pathology Imaging Systems Product Portfolio
- 8.20.5 3D-Histech Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst